Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

Enrolling by invitation · Phase 2

Conditions studied: Traumatic Brain Injury

In brief

Traumatic brain injury (TBI) causes acute deficits in cerebral perfusion which may lead to secondary injury and worse outcomes. Inhaled nitric oxide (iNO) is a vasodilator that increases cerebral blood flow and is clinically used for hypoxic respiratory failure in neonates and adults. The investigators will perform a randomized controlled trial of iNO treatment in TBI patients acutely after injury. The investigators will then assess perfusion changes with optic neuromonitoring, blood biomarkers, and 6 month clinical outcomes.

Key facts

Study ID
NCT05616910
Run by
University of Pennsylvania
People needed
38
Starts
2025-04-06
Expected to finish
2028-03-28
Last updated by the study team
2026-06-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.